Literature DB >> 21796462

Caroli's disease: report of surgical options and long-term outcome of patients treated in Argentina. Multicenter study.

Javier C Lendoire1, Gabriel Raffin, Jorge Grondona, Ricardo Bracco, Rodolfo Russi, Victoria Ardiles, Gabriel Gondolesi, Jorge Defelitto, Eduardo de Santibañes, Oscar Imventarza.   

Abstract

BACKGROUND: Caroli's disease (CD) management is still controversial. AIM: The purpose of this study is to report the most frequent clinical features, treatment options, and outcome obtained after surgical management of CD.
METHODS: A voluntary survey was conducted. Demographic, clinical, surgical, and pathological variables were analyzed.
RESULTS: Six centers included 24 patients having received surgical treatment from 1991 to 2009. Seventeen (70.8%) patients were female, with average age of 48.7 years old (20-71), and 95.5% were symptomatic. There was left hemiliver involvement in 75% of the patients. Surgical procedures included nine left lateral sectionectomies, eight left hepatectomies, and four right hepatectomies for those with hemiliver disease, while for patients with bilateral disease, one right hepatectomy and two Roux-en-Y hepaticojejunostomies were performed. The average length of hospitalization was 7 days. For perioperative complications (25%), three patients presented minor complications (types 1-2), while major complications occurred in three patients (type 3a). No mortality was reported. After a median follow-up of 166 months, all patients are alive and free of symptoms. CD diagnosis was confirmed by histology. Congenital hepatic fibrosis was present in two patients (8.3%) and cholangiocarcinoma in one (4.2%).
CONCLUSIONS: CD in Argentina is more common in females with left hemiliver involvement. Surgical resection is the best curative option in unilateral disease, providing long-term survival free of symptoms and complications. In selected cases of bilateral disease without parenchymal involvement, hepaticojejunostomy should be proposed. However, a close follow-up is mandatory because patients might progress and a transplant should be indicated.

Entities:  

Mesh:

Year:  2011        PMID: 21796462     DOI: 10.1007/s11605-011-1620-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  33 in total

1.  [Monolobar Caroli's disease. Apropos of 12 cases].

Authors:  M Gillet; S Favre; C Fontolliet; N Halkic; G Mantion; B Heyd
Journal:  Chirurgie       Date:  1999-02

2.  The role of liver transplantation in patients with Caroli's disease.

Authors:  F L Waechter; J A Sampaio; R D Pinto; M R Alvares-da-Silva; F G Cardoso; C Francisconi; L Pereira-Lima
Journal:  Hepatogastroenterology       Date:  2001 May-Jun

3.  Therapy of Caroli's disease by orthotopic liver transplantation.

Authors:  F Ulrich; T Steinmüller; U Settmacher; A R Müller; S Jonas; S G Tullius; P Neuhaus
Journal:  Transplant Proc       Date:  2002-09       Impact factor: 1.066

4.  [Congenital polycystic dilation of the intrahepatic bile ducts; attempt at classification].

Authors:  J CAROLI; R SOUPAULT; J KOSSAKOWSKI; L PLOCKER
Journal:  Sem Hop       Date:  1958-02-18

Review 5.  Partial hepatectomy is curative for the localized type of Caroli's disease: a case report and review of the literature.

Authors:  S Yilmaz; H Kirimlioglu; V Kirimlioglu; B Isik; S Coban; B Yildirim; C Ara; G Sogutlu; M Yilmaz
Journal:  Surgeon       Date:  2006-04       Impact factor: 2.392

6.  Caroli disease and the central dot sign.

Authors:  Neil U Lall; Mark J Hogan
Journal:  Pediatr Radiol       Date:  2009-02-17

Review 7.  Caroli's disease. Report of 5 cases and review of literature.

Authors:  R Madjov; P Chervenkov; V Madjova; B Balev
Journal:  Hepatogastroenterology       Date:  2005 Mar-Apr

8.  Caroli's disease: a magnetic resonance cholangiopancreatography diagnosis.

Authors:  T Asselah; O Ernst; G Sergent; C L'herminé; J C Paris
Journal:  Am J Gastroenterol       Date:  1998-01       Impact factor: 10.864

Review 9.  Ludwig symposium on biliary disorders--part I. Pathogenesis of ductal plate abnormalities.

Authors:  V J Desmet
Journal:  Mayo Clin Proc       Date:  1998-01       Impact factor: 7.616

10.  [Current therapy of bile duct cysts. II. Intrahepatic cysts (Caroli syndrome)].

Authors:  T Benhidjeb; J M Müller; K Gellert; J Zanow; B Rudolph
Journal:  Chirurg       Date:  1996-03       Impact factor: 0.955

View more
  7 in total

Review 1.  Choledochal cysts: presentation, clinical differentiation, and management.

Authors:  Kevin C Soares; Dean J Arnaoutakis; Ihab Kamel; Neda Rastegar; Robert Anders; Shishir Maithel; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2014-06-27       Impact factor: 6.113

2.  Epidemiology and Risk Factors of Cholangiocarcinoma.

Authors:  Martha M Kirstein; Arndt Vogel
Journal:  Visc Med       Date:  2016-12-01

3.  SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions.

Authors:  Yun Shin Chun; Michael G House; Harmeet Kaur; Evelyne M Loyer; Valérie Paradis; Jean-Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2013-02-02       Impact factor: 3.452

Review 4.  Surgical Management of Caroli's Disease: Single Center Experience and Review of the Literature.

Authors:  Maitham A Moslim; Ganesh Gunasekaran; David Vogt; Michael Cruise; Gareth Morris-Stiff
Journal:  J Gastrointest Surg       Date:  2015-08-25       Impact factor: 3.452

5.  Caroli's disease misdiagnosed as intraductal papillary neoplasm of the bile duct.

Authors:  Dae Hoe Gu; Min Seon Park; Chang Ho Jung; Yang Jae Yoo; Jae Young Cho; Yun Ho Lee; Yeon Seok Seo; Hyung Joon Yim; Soon Ho Um; Ho Sang Ryu
Journal:  Clin Mol Hepatol       Date:  2015-06-26

6.  Risk of malignancy in Caroli disease and syndrome: A systematic review.

Authors:  René Fahrner; Sandra Gc Dennler; Daniel Inderbitzin
Journal:  World J Gastroenterol       Date:  2020-08-21       Impact factor: 5.742

7.  Factors contributing to diagnostic delay of Caroli syndrome: a single-center, retrospective study.

Authors:  Wen Shi; Xiao-Ming Huang; Yun-Lu Feng; Feng-Dan Wang; Xiao-Xing Gao; Yang Jiao
Journal:  BMC Gastroenterol       Date:  2020-09-29       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.